Evaluation of persistent pulmonary infiltrate

Woodhead M, Blasi F, Ewig S, et al; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011 Nov;17 (Suppl 6):E1-59.Full text  Abstract

Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-67.Full text  Abstract

1. Menendez R, Perpina M, Torres A. Evaluation of non-resolving and progressive pneumonia. Semin Respir Infect. 2003 Jun;18(2):103-11. Abstract

2. Kuru T, Lynch JP 3rd. Non-resolving or slowly resolving pneumonia. Clin Chest Med. 1999 Sep;20(3):623-51. Abstract

3. Cunha BA. Slowly resolving and nonresolving pneumonias. Drugs Today (Barc). 2000 Dec;36(12):829-34. Abstract

4. Mittl RL Jr, Schwab RJ, Duchin JS, et al. Radiographic resolution of community-acquired pneumonia. Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):630-5. Abstract

5. Orens JB, Sitrin RG, Lynch JP 3rd. The approach to nonresolving pneumonia. Med Clin North Am. 2004 Feb;52(2):224-9. Abstract

6. El Solh AA, Aquilina AT, Gunen H, et al. Radiographic resolution of community-acquired bacterial pneumonia in the elderly. J Am Geriatr Soc. 2004 Feb;52(2):224-9. Abstract

7. Fein AM, Feinsilver SH, Niederman MS. Nonresolving or slowly resolving pneumonia: diagnosis and management in the elderly patient. Clin Chest Med. 1993 Sep;14(3):555-69. Abstract

8. Eisenberg GM, Flippin HF, Israel HL, et al. Delayed resolution of pneumonias. Med Clin North Am. 1956 Sep;40(5):1291-303. Abstract

9. Kirtland SH, Winterbauer RH. Slowly resolving, chronic, and recurrent pneumonia. Clin Chest Med. 1991 Jun;12(2):303-18. Abstract

10. Rome L, Murali G, Lippmann M. Nonresolving pneumonia and mimics of pneumonia. Med Clin North Am. 2001 Nov;85(6):1511-30, xi. Abstract

11. Fein AM, Feinsilver SH. Non-resolving and slowly resolving pneumonia. In: Feinsilver SH, Fein AM, eds. Textbook of bronchoscopy. Baltimore, MD: Williams & Wilkins; 1995:286-301.

12. Menendez R, Torres A, Zalacaín R, et al. Neumofail Group. Risk factors of treatment failure in community acquired pneumonia: implications for disease outcome. Thorax. 2004 Nov;59(11):960-5.Full text  Abstract

13. Menendez R, Torres A. Treatment failure in community-acquired pneumonia. Chest. 2007 Oct;132(4):1348-55. Abstract

14. Woodhead M, Blasi F, Ewig S, et al; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 2011 Nov;17 (Suppl 6):E1-59.Full text  Abstract

15. Cassiere H, Rodrigues JC, Fein AM. Delayed resolution of pneumonia: when is slow healing too slow? Postgrad Med. 1996 Jan;99(1):151-4, 157-8. Abstract

16. Arancibia F, Ewig S, Martinez JA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. Am J Respir Crit Care Med. 2000 Jul;162(1):154-60.Full text  Abstract

17. Gross TJ, Chavis AD, Lynch JP 3rd. Noninfectious pulmonary diseases masquerading as community-acquired pneumonia. Clin Chest Med. 1991 Jun;12(2):363-93. Abstract

18. Lynch JP 3rd, Sitrin RG. Noninfectious mimics of community acquired pneumonia. Semin Respir Infect. 1993 Mar;8(1):14-45. Abstract

19. Andrade CR, Ibiapina CC, Champs NS, et al. Avian influenza: the threat of the 21st century. J Bras Pneumol. 2009 May;35(5):470-9.Full text  Abstract

20. Low DE, Mazzulli T, Marrie T. Progressive and nonresolving pneumonia. Curr Opin Pulm Med. 2005 May;11(3):247-52. Abstract

21. Weyers CM, Leeper KV. Nonresolving pneumonia. Clin Chest Med. 2005 Mar;26(1):143-58. Abstract

22. Boyton RJ. Infectious lung complications in patients with HIV/AIDS. Curr Opin Pulm Med. 2005 May;11(3):203-7. Abstract

23. Kanmogne GD. Noninfectious pulmonary complications of HIV/AIDS. Curr Opin Pulm Med. 2005 May;11(3):208-12. Abstract

24. Shorr AF, Susla GM, O'Grady NP. Pulmonary infiltrate in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. Chest. 2004 Jan;125(1):260-71. Abstract

25. Crawford S. Noninfectious lung disease in the immunocompromised host. Respiration. 1999;66(5):385-95.Full text  Abstract

26. Maschmeyer G, Carratalà J, Buchheidt D, et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Oncol. 2015 Jan;26(1):21-33.Full text  Abstract

27. Leone S, Nicastri E, Giglio S, et al. Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review. Int J Infect Dis. 2010 Apr;14(4):e283-91. Abstract

28. Teramoto S, Matsuse T, Ouchi Y. Foreign body aspiration into the lower airways may not be unusual in older adults. Chest. 1998 Jun;113(6):1733-4. Abstract

29. Spickard A 3rd, Hirschmann JV. Exogenous lipoid pneumonia. Arch Intern Med. 1994 Mar 28;154(6):686-92. Abstract

30. Utz JP, Swensen SJ, Gertz MA. Pulmonary amyloidosis: the Mayo Clinic experience from 1980 to 1993. Ann Intern Med. 1996 Feb 15;124(4):407-13. Abstract

31. Rudiger A, Gasser S, Fischler M, et al. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure. Crit Care Med. 2006 Aug;34(8):2140-4. Abstract

32. Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation. 2002 May 21;105(20):2328-31. Abstract

33. Gluecker T, Capasso P, Schnyder P, et al. Clinical and radiologic features of pulmonary edema: a pictorial essay. Radiographics. 1999 Nov-Dec;19(6):1507-31.Full text  Abstract

34. van Belle A, Buller HR, Huisman MV, et al; Writing Group for the Christopher Study Investigators. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. JAMA. 2006 Jan 11;295(2):172-9.Full text  Abstract

35. Stein PD, Woodard PK, Weg JG, et al. Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med. 2006 Dec;119(12):1048-55. Abstract

36. Travis WD, Costabel U, Hansell DM, et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48.Full text  Abstract

37. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997 Sep;40(9):1725. Abstract

38. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315-24. Abstract

39. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol. 1988 Feb;15(2):202-5. Abstract

40. Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl. 2001 Sep;32:56s-68s.Full text  Abstract

41. Infante PF, Newman LS. Beryllium exposure and chronic beryllium disease. Lancet. 2004 Feb 7;363(9407):415-6. Abstract

42. Bégin R, Cantin A, Massé S. Recent advances in the pathogenesis and clinical assessment of mineral dust pneumoconioses: asbestosis, silicosis and coal pneumoconiosis. Eur Respir J. 1989 Nov;2(10):988-1001. Abstract

43. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med. 2004 Sep 15;170(6):691-715.Full text  Abstract

44. American Thoracic Society Committee of the Scientific Assembly on Environmental and Occupational Health. Adverse effects of crystalline silica exposure. Am J Respir Crit Care Med. 1997 Feb;155(2):761-8. Abstract

45. Schier JG, Meiman JG, Layden J, et al. Severe pulmonary disease associated with electronic-cigarette-product use - interim guidance. MMWR Morb Mortal Wkly Rep. 2019 Sep 13;68(36):787-90.Full text  Abstract

46. Alberts WM. Eosinophilic interstitial lung disease. Curr Opin Pulm Med. 2004 Sep;10(5):419-24. Abstract

47. Allen JN, Magro CM, King MA. The eosinophilic pneumonias. Semin Respir Crit Care Med. 2002 Apr;23(2):127-34. Abstract

48. Loffler W. Transient lung infiltrations with blood eosinophilia. Int Arch Allergy Appl Immunol. 1956;8(1-2):54-9. Abstract

49. Solomon J, Schwarz M. Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia. Semin Respir Crit Care Med. 2006 Apr;27(2):192-7. Abstract

50. Zander DS. Allergic bronchopulmonary aspergillosis: an overview. Arch Pathol Lab Med. 2005 Jul;129(7):924-8.Full text  Abstract

51. Lacasse Y, Selman M, Costabel U, et al. Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med. 2003 Oct 15;168(8):952-8.Full text  Abstract

52. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med. 2004 Sep;25(3):531-47. Abstract

53. Silva CI, Churg A, Muller NL. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. AJR Am J Roentgenol. 2007 Feb;188(2):334-44.Full text  Abstract

54. Shah PL, Hansell D, Lawson PR, et al. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax. 2000 Jan;55(1):67-77.Full text  Abstract

55. Seymour JF, Presneill JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med. 2002 Jul 15;166(2):215-35.Full text  Abstract

56. Camus P, Bonniaud P, Fanton A, et al. Drug-induced and iatrogenic infiltrative lung disease. Clin Chest Med. 2004 Sep;25(3):479-519. Abstract

57. Erasmus JJ, McAdams HP, Rossi SE. Drug-induced lung injury. Semin Roentgenol. 2002 Jan;37(1):72-81. Abstract

58. Camus P. Pneumotox online: the drug-induced respiratory disease website. Vol. 2, 2012 [internet publication].Full text

59. Carver JR, Shapiro CL, Ng A, et al. ASCO Cancer Survivorship Expert Panel. American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol. 2007 Sep 1;25(25):3991-4008.Full text  Abstract

60. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020 Jan 21;41(4):543-603.Full text

61. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost. 2000 Mar;83(3):416-20. Abstract

62. Le Gal G, Righini M, Roy PM, et al. Prediction of pulmonary embolism in the emergency department: the revised Geneva score. Ann Intern Med. 2006 Feb 7;144(3):165-71. Abstract

63. Raja AS, Greenberg JO, Qaseem A, et al. Evaluation of patients with suspected acute pulmonary embolism: best practice advice from the clinical guidelines committee of the American College of Physicians. Ann Intern Med. 2015 Nov 3;163(9):701-11.Full text  Abstract

64. National Institute for Health and Care Excellence. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. Aug 2023 [internet publication].Full text

65. Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021 Dec;160(6):e545-608.Full text  Abstract

66. Wimalasena Y, Kocierz L, Strong D, et al. Lung ultrasound: a useful tool in the assessment of the dyspnoeic patient in the emergency department. Fact or fiction? Emerg Med J. 2018 Apr;35(4):258-66. Abstract

67. National Institute for Health and Care Excellence. Acute heart failure: diagnosis and management. Nov 2021 [internet publication].Full text

68. Centers for Disease Control and Prevention. Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis. Jan 2009 [internet publication].Full text

69. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med. 2004 Sep;25(3):583-92. Abstract

70. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003 Feb 15;361(9357):587-94. Abstract

71. Depascale R, Del Frate G, Gasparotto M, et al. Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature review. Ther Adv Musculoskelet Dis. 2021;13:1759720X211040696.Full text  Abstract

72. National Institute for Health and Care Excellence. Idiopathic pulmonary fibrosis in adults: diagnosis and management. May 2017 [internet publication].Full text

73. Spicknall KE, Zirwas MJ, English JC 3rd. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. 2005 Jun;52(6):1020-8. Abstract

74. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-67.Full text  Abstract

75. Sordé R, Falcó V, Lowak M, et al. Current and potential usefulness of pneumococcal urinary antigen detection in hospitalized patients with community-acquired pneumonia to guide antimicrobial therapy. Arch Intern Med. 2011 Jan 24;171(2):166-72. Abstract

76. Shen KR, Bribriesco A, Crabtree T, et al. The American Association for Thoracic Surgery consensus guidelines for the management of empyema. J Thorac Cardiovasc Surg. 2017 Jun;153(6):e129-46. Abstract

77. Martin-Loeches I, Torres A, Nagavci B, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J. 2023 Apr 3;61(4):2200735.Full text  Abstract

78. Kearon C, Ginsberg JS, Douketis J, et al. An evaluation of D-dimer in the diagnosis of pulmonary embolism: a randomized trial. Ann Intern Med. 2006 Jun 6;144(11):812-21. Abstract

79. Wells PS, Ginsberg JS, Anderson DR, et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med. 1998 Dec 15;129(12):997-1005. Abstract

80. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007 Nov 22;357(21):2153-65.Full text  Abstract

81. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest 2004 Dec;25(4):637-49. Abstract

82. Feinsilver SH, Fein AM, Niederman MS, et al. Utility of fiberoptic bronchoscopy in nonresolving pneumonia. Chest. 1990 Dec;98(6):1322-6. Abstract

83. Korevaar DA, Colella S, Fally M, et al. European Respiratory Society guidelines on transbronchial lung cryobiopsy in the diagnosis of interstitial lung diseases. Eur Respir J. 2022 Nov 10;60(5):2200425.Full text  Abstract

84. Ebell MH, Bentivegna M, Cai X, et al. Accuracy of biomarkers for the diagnosis of adult community-acquired pneumonia: a meta-analysis. Acad Emerg Med. 2020 Mar;27(3):195-206.Full text  Abstract

85. Detterbeck FC, Lewis SZ, Diekemper R, et al. Executive summary diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013 May; 143(5 Suppl):7S–37S. Abstract

86. Lewinsohn DM, Leonard MK, LoBue PA, et al. Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children. Clin Infect Dis. 2017 Jan 15;64(2):e1-33.Full text  Abstract

87. Geldmacher H, Taube C, Kroeger C, et al. Assessment of lymph node tuberculosis in northern Germany: a clinical review. Chest. 2002 Apr;121(4):1177-82.Full text  Abstract

88. Weir MR, Thornton GF. Extrapulmonary tuberculosis. Experience of a community hospital and review of the literature. Am J Med. 1985 Oct;79(4):467-78. Abstract

89. Baydur A. The spectrum of extrapulmonary tuberculosis. West J Med. 1977 Apr;126(4):253-62.Full text  Abstract

90. World Health Organization.​ WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection. Mar 2024 [internet publication].Full text

91. Bjerrum S, Schiller I, Dendukuri N, et al. Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV. Cochrane Database Syst Rev. 2019 Oct 21;10(10):CD011420.Full text  Abstract

92. Centers for Disease Control and Prevention. Laboratory testing for the diagnosis of HIV infection : updated recommendations. Jun 2014 [internet publication].Full text

93. Thillai M, Atkins CP, Crawshaw A, et al. BTS clinical statement on pulmonary sarcoidosis. Thorax. 2021 Jan;76(1):4-20.Full text

94. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS board of directors and by the ERS executive committee, February 1999. Am J Respir Crit Care Med. 1999 Aug;160(2):736-55.Full text

95. Raghu G, Remy-Jardin M, Richeldi L, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022 May 1;205(9):e18-47.Full text  Abstract

96. Kohsaka H, Mimori T, Kanda T, et al. Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists. Mod Rheumatol. 2019 Jan;29(1):1-19. Abstract

97. Blaho K, Logan B, Winbery S, et al. Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED. Am J Emerg Med. 2000 Sep;18(5):593-8. Abstract